The Prognostic Role of Cortisol and Glucose Dynamics in Cardiogenic Shock-Insights from a Prospective Observational

Priyanka Boettger1, Laura Pallmann2, Jamschid Sedighi3

  • 1Department of Internal Medicine I, Cardiology, Angiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Klinikstrasse 33, 35392, Giessen, Hessen, Germany. Priyanka.boettger@uni-giessen.de.

Insights

High glucose and cortisol levels after heart attack-related cardiogenic shock (CS) predict mortality. Early normalization of glucose improves survival, highlighting metabolic markers as key targets for intervention.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Medicine

Background:

  • Cardiogenic shock (CS) following myocardial infarction has a high mortality rate.
  • The prognostic significance of dynamic metabolic markers, specifically glucose and cortisol, in CS is not fully understood.

Purpose of the Study:

  • To investigate the prognostic value of serial glucose and cortisol measurements in patients with myocardial infarction-related CS.
  • To identify metabolic markers that predict in-hospital mortality in this patient population.

Main Methods:

  • Prospective cohort study of 41 patients with infarction-related CS.
  • Serial blood sampling over 96 hours to measure plasma glucose and serum cortisol levels.
  • Primary endpoint: in-hospital mortality.

Main Results:

  • Admission glucose levels showed a trend towards increased mortality (36.4% for <10 mmol/L, 43.8% for 10-15 mmol/L, 50.0% for >15 mmol/L).
  • Early glucose normalization (≤6 hours) was associated with improved survival (25% vs. 45%).
  • Survivors had a rapid decline in cortisol levels, while non-survivors had persistently high levels (p=0.016 for AUC₀-₉₆).

Conclusions:

  • Early and sustained hyperglycemia and hypercortisolemia are independent predictors of mortality in infarction-related CS.
  • These metabolic derangements represent potential targets for therapeutic intervention to improve outcomes.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
826
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.8K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
465
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
4.5K